Brief: Precipio Shareholders To Expect More Quarter-To-Quarter Volatility In Pathology Division Revenue
Dec 14 (Reuters) - Precipio Inc PRPO.O :
* PRECIPIO INC: SHAREHOLDERS TO EXPECT MORE
QUARTER-TO-QUARTER
VOLATILITY IN PATHOLOGY DIVISION REVENUE THAN IN PRODUCT
DIVISION REVENUE
* PRECIPIO INC: EXPECT Q4-2023 REVENUES TO BE ABOUT
$3.2-$3.5M,
AND END 2023 WITH ESTIMATED REVENUES FOR YEAR OF ABOUT $14.5M
Source text for Eikon: ID:
Further company coverage: PRPO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precipio
See all newsCancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
Precipio Q1 revenue rises on higher pathology sales
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Brief: Precipio Identifies Unauthorized Access To Isolated Storage No Operational Impact
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers